JUMP is a natural history study to understand the disease and treatment experience of patients with methylmalonic acidemia (MMA) and propionic acidemia (PA).
JUMP is being conducted by rare disease online research platform AllStripes in collaboration with HemoShear Therapeutics. HemoShear is also developing HST5040, an oral small molecule for the treatment of MMA and PA.
HemoShear Therapeutics, Inc.
501 Locust Avenue
Charlottesville, Virginia 22902